Predictive Factors of Autonomy Loss in Real-life Cohort
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The Investigators aim at developing a regional database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative staff and with the University hospital computer science departments. The main objective is to study the predictive factors associated with change in functional autonomy level, measured every 6 to 12 months in centres across Region Auvergne Rhone-Alpes in France. The real-life study population will consist in about 5400 patients with ADRD. The inclusion period will be of 3 years, the length of follow-up of each patient will be of 10 years max for a total study length of 13 years.
Sponsor: Hospices Civils de Lyon
You may qualify if…
- ✓ Patients aged 18 years and older, undergoing a medical visit in a memory center or neuro-cognition service
- ✓ Patients living at home or in housing
- ✓ Patients with memory impairment, at all stage of the disease
You may not qualify if…
- ✕ Patients in institution
- ✕ Patients under legal protection
- ✕ Patients with a hearing or visual impairment, which prevents carrying out examinations
Source: ClinicalTrials.gov · NCT03894254 · last updated 2022-05-02